Eun Hwa Kim

Array ( [id] => 3766385 [patent_doc_number] => 05773218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Method to identify compounds which modulate ICAM-related protein interactions' [patent_app_type] => 1 [patent_app_number] => 8/482882 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 54396 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773218.pdf [firstpage_image] =>[orig_patent_app_number] => 482882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850516 [patent_doc_number] => 05767077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Human Fc-.gamma. receptor III' [patent_app_type] => 1 [patent_app_number] => 8/481939 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6128 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767077.pdf [firstpage_image] =>[orig_patent_app_number] => 481939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818380 [patent_doc_number] => 05770686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'ICAM-related protein fragments' [patent_app_type] => 1 [patent_app_number] => 8/474368 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 38 [patent_no_of_words] => 35716 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770686.pdf [firstpage_image] =>[orig_patent_app_number] => 474368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726060 [patent_doc_number] => 05702917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Polynucleotides encoding human ICAM-4' [patent_app_type] => 1 [patent_app_number] => 8/481130 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15686 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702917.pdf [firstpage_image] =>[orig_patent_app_number] => 481130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790424 [patent_doc_number] => 05780263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Human CCN-like growth factor' [patent_app_type] => 1 [patent_app_number] => 8/468847 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13078 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780263.pdf [firstpage_image] =>[orig_patent_app_number] => 468847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890206 [patent_doc_number] => 05834425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Use of chimeric selectins as simultaneous blocking agents for component selectin function' [patent_app_type] => 1 [patent_app_number] => 8/461592 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 7946 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834425.pdf [firstpage_image] =>[orig_patent_app_number] => 461592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847137 [patent_doc_number] => 05766857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Isolation and use of fibronectin receptor' [patent_app_type] => 1 [patent_app_number] => 8/468480 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 5816 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766857.pdf [firstpage_image] =>[orig_patent_app_number] => 468480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3873830 [patent_doc_number] => 05747280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Human vascular IBP-like growth factor' [patent_app_type] => 1 [patent_app_number] => 8/464339 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13597 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747280.pdf [firstpage_image] =>[orig_patent_app_number] => 464339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3758770 [patent_doc_number] => 05851795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Soluble CTLA4 molecules and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/459818 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 43 [patent_no_of_words] => 26175 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851795.pdf [firstpage_image] =>[orig_patent_app_number] => 459818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3800313 [patent_doc_number] => 05830504 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Cooperative combinations of ligands contained within a matrix' [patent_app_type] => 1 [patent_app_number] => 8/456878 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 11029 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830504.pdf [firstpage_image] =>[orig_patent_app_number] => 456878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769829 [patent_doc_number] => 05849687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Acid-labile subunit als of insulin-like growth factor binding proteincomplex' [patent_app_type] => 1 [patent_app_number] => 8/460452 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 10340 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849687.pdf [firstpage_image] =>[orig_patent_app_number] => 460452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688841 [patent_doc_number] => 05663300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Protocadherin-42' [patent_app_type] => 1 [patent_app_number] => 8/453274 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14629 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663300.pdf [firstpage_image] =>[orig_patent_app_number] => 453274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621128 [patent_doc_number] => 05641743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Therapeutic compositions and methods for use of heparin-binding brain mitogens' [patent_app_type] => 1 [patent_app_number] => 8/451336 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6202 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641743.pdf [firstpage_image] =>[orig_patent_app_number] => 451336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3865967 [patent_doc_number] => 05837486 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Method for preparing soluble analogues of integrins' [patent_app_type] => 1 [patent_app_number] => 8/445443 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13950 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837486.pdf [firstpage_image] =>[orig_patent_app_number] => 445443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3794693 [patent_doc_number] => 05726290 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Soluble analogues of integrins' [patent_app_type] => 1 [patent_app_number] => 8/445042 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14967 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726290.pdf [firstpage_image] =>[orig_patent_app_number] => 445042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790946 [patent_doc_number] => 05726037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Host cells and method of producing soluble analogues of integrins' [patent_app_type] => 1 [patent_app_number] => 8/444792 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14950 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726037.pdf [firstpage_image] =>[orig_patent_app_number] => 444792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657401 [patent_doc_number] => 05658877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Method to treat endotoxin effects by administration of 33 kilodalton phospholipid binding protein' [patent_app_type] => 1 [patent_app_number] => 8/443511 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5995 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658877.pdf [firstpage_image] =>[orig_patent_app_number] => 443511 [rel_patent_id] =>[rel_patent_doc_number] =>)